增量氯吡格雷对中重度脑动脉狭窄CYP2C19中间代谢型脑梗死预后影响的临床观察

张小红, 贺鹏, 罗奎, 刘建华, 刘敏

中国医院药学杂志 ›› 2019, Vol. 39 ›› Issue (15) : 1566-1569.

PDF(552 KB)
PDF(552 KB)
中国医院药学杂志 ›› 2019, Vol. 39 ›› Issue (15) : 1566-1569. DOI: 10.13286/j.cnki.chinhosppharmacyj.2019.15.12
药物与临床

增量氯吡格雷对中重度脑动脉狭窄CYP2C19中间代谢型脑梗死预后影响的临床观察

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Clinical observation of the effect of dual antiplatelet therapy with conventional dose and incremental clopidogrel on prognosis of intermediate metabolic cerebral infarction in patients with moderate to severe cerebral artery stenosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
文章历史 +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

本文二维码

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}[J]. {{journal.qiKanMingCheng_CN}}, 2019, 39(15): 1566-1569 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2019.15.12
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 39(15): 1566-1569 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2019.15.12
中图分类号:

参考文献

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(552 KB)

Accesses

Citation

Detail

段落导航
相关文章

/